Advances in alternative pharmacotherapy of ADHD.
Article
in English
| IMSEAR
| ID: sea-39859
ABSTRACT
Several alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Piperidines
/
Attention Deficit Disorder with Hyperactivity
/
Humans
/
Treatment Outcome
/
Bupropion
/
Clonidine
/
Adrenergic alpha-Agonists
/
Indans
/
Antidepressive Agents, Tricyclic
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS